Diabetes is a chronic metabolic disorder characterized by high blood glucoselevels overaprolongedperiod, resultingfromeitherinsufficientinsulin productionbythepancreas (Type1 diabetes)orineffectiveuseofinsulin bythebody\'s cells (Type2 diabetes). Diabetes can lead to severe health complications, including cardiovascular disease, kidney failure, nerve damage, and vision impairment if not managed properly. It is a significant global health issue, impacting millions and associated with lifestyle, genetic factors, and environmental influences. Management of diabetes involves regular monitoring of blood glucose levels, dietarymodifications, physical activity, and sometimes medication or insulin therapy. Prevention efforts focus on lifestyle changes, especially in populations at high risk for Type 2 diabetes. Early diagnosis and intervention are crucial for reducing long-term health risks associated with diabetes.
Introduction
Diabetes mellitus is a group of metabolic disorders characterized by persistent high blood sugar due to inadequate insulin production, action, or both. Insulin deficiency disrupts carbohydrate, fat, and protein metabolism, caused by insufficient insulin levels and/or insulin resistance primarily affecting muscle, fat, and liver tissues. Symptoms and severity vary by diabetes type and duration, ranging from no symptoms to serious complications like ketoacidosis or coma if untreated.
Globally, diabetes affects 828 million people, with India alone accounting for about 212 million cases—one of the highest burdens worldwide. Most Indian cases (90-95%) are type 2 diabetes, often linked to lifestyle changes such as increased urbanization, industrialization, dietary shifts toward animal fats, and sedentary habits. Diabetes prevalence in India is rising rapidly, with significant urban-rural disparities and high rates of diabetic complications like retinopathy.
Diabetes is classified mainly into three types:
Type 1 Diabetes: An autoimmune disease causing destruction of insulin-producing pancreatic β-cells, commonly in children and teens.
Type 2 Diabetes: Accounts for 90-95% of cases, driven by insulin resistance often associated with obesity and lifestyle factors, increasingly seen in younger populations.
Gestational Diabetes: Develops during pregnancy due to hormonal changes, affecting blood sugar control.
The pathophysiology involves genetic, environmental, and lifestyle factors. Type 1 diabetes results from immune-mediated β-cell destruction causing insulin deficiency, while type 2 diabetes involves insulin resistance and impaired insulin secretion. Gestational diabetes arises from hormonal changes during pregnancy, with risk factors including obesity and family history.
Historically, diabetes understanding has evolved from early descriptions by Aretaeus to the discovery of insulin by Banting and colleagues in 1923. Contemporary research explores diabetes subtypes, mechanisms like oxidative stress, and protective roles of hormones like estradiol on β-cells.
Conclusion
Diabetes is achronic medical conditionwherethe bodyeitherdoesnotproduce enough insulin or cannot effectively use the insulin it produces. This results in elevated blood sugar levels, which can lead to serious complications if not managed. Proper managementthroughahealthydiet,regularexercise,medicationandregularmonitoringcan help individual’s live healthier lives and reduce the risk of complications. Fenugreek, moringa, Ficus racemosa, and coca plants have shown potential Antidaibetic properties due to their ability to regulate blood sugar levels, improve insulin sensitivity, and reduce oxidative stress. These plants contain bioactive compounds that may complement diabetes management, but further research and clinical studies are needed for confirmation and safe therapeutic use.
References
[1] AmericanDiabetesAssociation.Diagnosisandclassificationofdiabetesmellitus. Diabetes Care, 37 Suppl 1: year-2014, page no.581-590.
[2] CraigME,HattersleyA,et.al.?Definition,epidemiologyandclassificationofdiabetesin children and adolescents Pediatric Diabetes 10 Suppl 12? year -2009, page no.3-12
[3] Galtier F. et.al. ?Definition, epidemiology, risk factors. Diabetes Mehtab 36.year-2010, page no.628-651
[4] WorldDiabetesDay 2024:One-fourthofpeoplelivingwithdiabetesglobally arein India, study estimates. The Hindu. year-2024,page no.212-218
[5] https://www.thehindu.com/news/national/one-fourth-of-people-living-with-diabetes-in-india-lancet-study-estimates/article68866422.eceLess Than a Third of People Suffering from Diabetes Get Treatment in India, World\'s Diabetes. Capital.year-2014, page no.321-328. https://thewire.in/health/one-third-diabetes-treatment-India-capital.
[6] GeoffreyMigiro. et.al. Countries by Percentage of World Population world meters.? Year-2024, pageno.237-245.https://www.worldometers.info/world-population/india-population.
[7] \"Over30millionhavenowbeen diagnosedwith diabetesin India.TheCPRintheurban areas of India is thought to be 9 per cent\" year-2020, page no.267-272. (https://www.diabetes.co.uk/global-d diabetes/diabetes-in-india.html).
[8] Mohan, V. et.al. The Journal of the AssociationofPhysiciansofIndia.52: Year-2004, page no.468-474. (https://pubmed.ncbi.nlm.nih.gov/15645957)
[9] DiabetesinAsia.AmericanMedicalAssociation.Year.2009,pageno.267-272. (https://jamanetwork.com/journals/jama/article-abstract/183977)
[10] Prakash,Shetty et.al.?NutritiontransitioninIndia-via Public HealthNutrition.year- 2002,Pageno.175182.(https://www.cambridge.org/core/journals/publichealthnutrition/article/nutrition-transition-inindia/8B3C4A71EE883791E4AF0828E43BD4 B9)
[11] \"Members\"year-2020.(https://idf.org/ournetwork/regionsmembers/southeastasia/members/94-india.Html).idf.org.
[12] Ramachandran, Ambady; Snehalatha, et.al. ?Diabetes in South-East Asia: An update Diabetes Research and Clinical Practice, 103(2)year-2014, pageno.-231-237. (https://pubmed.ncbi.nlm.nih.gov )
[13] Diabetes country profiles-World Health Organization? year.2020, page no.-237-240. (https://www.who.int/diabetes/country-profiles/inden.pdf)
[14] Sharma,NeetuChandra,et.al.?Governmentsurveyfound11.8%prevalenceofdiabetes in India.?Year.-2020, pageno.-328-335.
[15] (https://www.livemint.com/science/health/government-survey-found-11-8-prevalence-of-diabetes-in-india-11570702665713.html)
[16] Chandrupatla,SiddardhaGowtam, et.al. ?Diabetes and prediabetes PrevalenceAmong Young and Middle Aged Adults, And Geographic Differences In India- National Family.?Year.-2020, page no.421-429 (https://pubmed.ncbi.nlm.nih.gov/32972049).
[17] \"Diabetesin India\" year.2020,page no.432-438. (https://cadiresearch.org/topic/diabetes- indians/diabetes-in-india)
[18] Atre, Sachin at.al. ?The burden of diabetes in India, The Lancet Global Health year.2019, page no.435-438. (https://pubmed.ncbi.nl m.nih.gov/30879507)
[19] Newsub-groupsofdiabetescouldleadtomoretargetedtreatment forpeoplein India\" National Institute for Health and Care Research.?year.2021, pageno.123-129. https://api.semanticscholar.org/Corpus ID:241327246
[20] Anjana,Ranjit Mohan, et.al ?Novel subgroups of type 2 diabetes and their association with micro vascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.?year.-2020, page no.129-132.
[21] (https://pubmed.ncbi.nlm.nih.gov/32816869).
[22] Marianna Karamanou, Athanase Protogerou, et.al. World Journal Of Diabetes, Milestones in the history of diabetes mellitus: The main contributors.volume-7, Issue- 1,year.- 2016 Page no.1-7.
[23] G.Li,T.Wei,W.Ni,A.Zhang,et.al.?Incidenceandriskfactorsofgestationaldiabetes mellitus: a prospective cohort study in Qingdao, China Front. Endocrinol.year.2020, page no.239-245.
[24] M.Banday, A. Sameer, S. Nissaret.al. ?Pathophysiology of diabetes: an overview Avicenna J. Med.? year.2020, page no. 174-188.
[25] R.Khardoriet.al.Type2DiabetesMellitus:PracticeEssentials,Background, Pathophysiology E Medicine? year2022, page no.188-191.
[26] https://emedicine.medscape.com/article/117853-overview#a3
[27] KDTRIPATHIMDet.al.EssentialsofMedicalPharmacology,6thedition,2008,Pageno.266-272.
[28] https://www.researchgate.net/publication/328335127_Moringa_oleifera_Shajna_the_wonderful_indigenousmedicinal_plant
[29] Hafizur, R.M.; Maryam, K.; et al. Insulin-releasing effect of some pure compounds from Moringa oleifera on mice islets. Med. Chem. Res.? Year.2018, page no.1408– 1418.
[30] SainiRK, ShettyNP, et.al. Carotenoid content in vegetative and reproductive parts of commercially grown Moringa oleifera Lam. cultivars from India by LC–APCI–MS. Eur Food Res Technol. year.2014, page no.238-971.
[31] SainiRK,ShettyNP, et.al.Effectofdehydrationmethodsonretentionofcarotenoids, tocopherols, ascorbic acid and antioxidant activity in Moringa oleifera leaves and preparation of a RTE product. J Food Sci Technol.year.2014, page no.234-244.
[32] Amaglo NK, Bennett RN, et al. Profiling selected phytochemicals and nutrients in different tissues of the multipurpose tree Moringa oleifera L. grown in Ghana. Food Chem.? Year.2010, page no.252-258.
[33] CoppinJP, Xu Y, et al. Determination of flavonoids by LC/MS and anti-inflammatory activity in Moringa oleifera. J Funct Foods. year. - 2013, page no.617-621.
[34] Saini RK, Manoj P, Shetty NP. et.al. Relative bioavailability of folate from the traditional food plant Moringa oleifera L. as evaluated in a rat model Technol.? year.2016, page no.134-139.
[35] Saini RK, Shetty NP, Giridhar P.et.al. Analysis of fatty acids in Indian cultivars of Moringa oleifera: potential sources of PUFA. J Am Oil Chem Soc.? year.2014, page no.99-112.
[36] SainiRK, Manoj P, et.al. Dietary iron supplements and Moringa oleifera leaves influence the liver hepcidin messenger RNAexpression and biochemical indices of iron status in rats. year.2014, page no.77-81.
[37] BennettR.N,MellonF.A,etal.Profilingglucosinolatesandphenolicsinvegetativeand reproductive tissues of the multi-purpose trees Moringa oleifera L.? year. - 2003, page no.23-30.
[38] https://chatgpt.com/share/6739a333-0008-8001-a67e-64cefa794fc9
[39] https://www.sciencedirect.com/science/article/abs/pii/B9780128131480000281
[40] Saleh Ali Alqadoori, Farah Ali Dawood, at.al.INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH, Active Ingredients and Antidiabetic Activity of Fenugreek: AReviewArticle, Volume 03, Issue,? year 2024, page no.593-596.
[41] https://chatgpt.com/share/6739b7c5-8054-800e-a99e-7662c50e3ca2
[42] https://www.journalijdr.com/sites/default/files/issue-pdf/27899.pdf
[43] BaslasRK,AghaR.et.al.IsolationofahypoglycemicprinciplefromthebarkofFicus glomerata Roxb. Himalayan Chem Pharm Bull.Year.1985, page no.45-48.
[44] Kar.A,Choudhary.B.K, et.al. Comparative evaluation of hypoglycemic activity of some Indian Medicinal Plants in alloxan diabetic rats. J Ethnopharmacol.year.2003, page no.222-226.
[45] BhaskaraRR, MurugesanT, et.al. Glucose lowering efficacyof Ficus racemosa barks extract in normal and alloxan diabetic rats. Year. - 2002, page no.236-240.
[46] AkhtarMS, QureshiAQ.et.al. In vitro studies on the hypoglycemic potential of Ficus racemosa stem bark Pakistan. J Pharm Sci.year.1988, page no.877–889.
[47] Ahmed F, Urooj A. et.al. In vitro studies on the hypoglycemic potential of Ficus racemosa Stem bark. J Sci Food Agric. year.2010,page no.90-97
[48] https://chatgpt.com/share/6739b82e-cce0-800c-9b81-c94cfcd0f73b.
[49] https://www.slideshare.net/slideshow/cocoa-14368000/14368000
[50] htpp://com.whatsapp.provider.media/item/7b1a0ec1-9238-42c3-9244-aaa3280e9df7
[51] content://com.whatsapp.provider.media/item/93458b6c-cb22-401b-9b3c-f9b4ec415bb1
[52] https://chatgpt.com/share/673abbf1-3814-8001-8139-2a55668244aa
[53] Mr.GhugeJagnnath Ramprasad, Miss. Kale Vidya Raosaheb et.al. Formulation and Evaluation of Antidiabetic Chocolate by using Guava Leaves and MulberryFruits, Volume 5,Issue 1,year-2023,page no.1-6
[54] Yogesh S.K olekar1,Sajid A. Mulani et.al. FORMULATION AND EVALUATION OF PEDIATRIC HERBAL CHOCOLATE, Volume 8,Issue 6,year-2021,page no.458-462
[55] Najmin Ansar Shaikh1, Sakshi Omprakash Jaju et.al. “FORMULATION AND EVALUATION OF ANTIDIABETIC HERBALCHOCOLATES CONTAINING GUAVA LEAVES AND AEGLE MARMELOS LEAVES”, Volume 9, Issue 5,year-2024,page no.73-83
[56] Nimbalkar Pawan Asaram et.al. “PREPARATION AND EVALUATION OF SUGAR FREE ANTIDIABETIC CHOCOLATE BY USING GUAVA LEAVES”,Volume 6, Issue 6,year-2024,page no.4280-4288.